Nitroheterocyclic drugs as selective radiosensitizers of hypoxic mammalian cells.
D000818:Animals; D002478:Cells, Cultured / Q000528:radiation effects*; D055598:Chemical Phenomena; D002621:Chemistry; D006224:Cricetinae; D004273:DNA, Neoplasm / Q000528:radiation effects; D004058:Diffusion; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D006571:Heterocyclic Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D009369:Neoplasms / Q000378:metabolism / Q000532:radiotherapy; D009574:Nitro Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D009578:Nitrobenzenes / Q000494:pharmacology; D009581:Nitrofurans / Q000494:pharmacology; D010100:Oxygen; D010101:Oxygen Consumption; D011830:Radiation Effects; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D013997:Time Factors
D004273:DNA, Neoplasm; D006571:Heterocyclic Compounds; D009574:Nitro Compounds; D009578:Nitrobenzenes; D009581:Nitrofurans; D011838:Radiation-Sensitizing Agents; D010100:Oxygen